Poly(ethylene glycol)-conjugated anti-EGF receptor antibody C225 with radiometal chelator attached to the termini of polymer chains - PubMed (original) (raw)
. 2001 Jul-Aug;12(4):545-53.
doi: 10.1021/bc0001443.
Affiliations
- PMID: 11459459
- DOI: 10.1021/bc0001443
Poly(ethylene glycol)-conjugated anti-EGF receptor antibody C225 with radiometal chelator attached to the termini of polymer chains
X Wen et al. Bioconjug Chem. 2001 Jul-Aug.
Abstract
Several biological barriers, including significant liver uptake, limit the clinical application of radiolabeled antibodies in radioimmunoscintigraphy. Here, a general approach is described for radiolabeling of monoclonal antibodies conjugated with poly(ethylene glycol) (PEG). This strategy is demonstrated with C225, a monoclonal antibody directed against epidermal growth factor (EGF) receptor. We synthesized a heterofunctional PEG with one end attached to a radiometal chelator, diethylenetriaminepentaacetic acid (DTPA), and the other end to a protected thiol group, S-acetylthioacetate. After a deprotection step, the resulting DTPA-PEG-SH was conjugated to maleimide-activated C225 to yield DTPA-PEG-C225 conjugate. Characterization of DTPA-PEG-C225 with immunoprecipitation and Western blot analysis revealed that the conjugate was biologically active in binding to the EGF receptor in A431 cells. Competitive EGF receptor binding assay in MDA-MB-468 cells showed that DTPA-PEG-C225, with up to 60% of the amino groups in C225 substituted, retained 66% of C225's binding affinity. Moreover, DTPA-PEG-C225 with increasing degrees of NH(2) substitution from 20% to 70% retained the activity of C225 to induce apoptosis in DiFi cells. More importantly, DTPA-PEG-C225 demonstrated less nonspecific interaction than DTPA-C225. Pharmacokinetic analysis using (111)In-labeled compounds revealed narrower steady-state distribution of (111)In-DTPA-PEG-C225 than (111)In-DTPA-C225, probably due to reduced nonspecific binding of PEG-modified antibody to tissues. The terminal half-life (t(1/2,)(gamma)) of (111)In-DTPA-PEG-C225, 21.1 h, was shorter than that of (111)In-DTPA-C225, 52.9 h. These data suggest that (111)In-DTPA-PEG-C225 may provide better imaging characteristics than (111)In-DTPA-C225, and that using PEG as a linker between the monoclonal antibody and DTPA may be a promising strategy in optimizing the imaging characteristics of immunoscintigraphic agents.
Similar articles
- Targeting doxorubicin to epidermal growth factor receptors by site-specific conjugation of C225 to poly(L-glutamic acid) through a polyethylene glycol spacer.
Vega J, Ke S, Fan Z, Wallace S, Charsangavej C, Li C. Vega J, et al. Pharm Res. 2003 May;20(5):826-32. doi: 10.1023/a:1023454107190. Pharm Res. 2003. PMID: 12751641 - Conjugation with (111)In-DTPA-poly(ethylene glycol) improves imaging of anti-EGF receptor antibody C225.
Wen X, Wu QP, Ke S, Ellis L, Charnsangavej C, Delpassand AS, Wallace S, Li C. Wen X, et al. J Nucl Med. 2001 Oct;42(10):1530-7. J Nucl Med. 2001. PMID: 11585869 - Imaging taxane-induced tumor apoptosis using PEGylated, 111In-labeled annexin V.
Ke S, Wen X, Wu QP, Wallace S, Charnsangavej C, Stachowiak AM, Stephens CL, Abbruzzese JL, Podoloff DA, Li C. Ke S, et al. J Nucl Med. 2004 Jan;45(1):108-15. J Nucl Med. 2004. PMID: 14734682 - 111In-DTPA-Poly(ethylene glycol)-anti-epidermal growth factor receptor antibody C225.
The MICAD Research Team. The MICAD Research Team. 2007 Jun 7 [updated 2007 Jul 2]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. 2007 Jun 7 [updated 2007 Jul 2]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013. PMID: 20641771 Free Books & Documents. Review. - IMC-C225, an anti-epidermal growth factor receptor monoclonal antibody, for treatment of head and neck cancer.
Herbst RS, Kim ES, Harari PM. Herbst RS, et al. Expert Opin Biol Ther. 2001 Jul;1(4):719-32. doi: 10.1517/14712598.1.4.719. Expert Opin Biol Ther. 2001. PMID: 11727507 Review.
Cited by
- Dextran-conjugated vascular endothelial growth factor receptor antibody for in vivo melanoma xenografted mouse imaging.
Kim EM, Jeong HJ, Jeong MH, Lee CM, Cheong SJ, Kim DW, Lim ST, Sohn MH. Kim EM, et al. Cancer Biother Radiopharm. 2012 Mar;27(2):141-8. doi: 10.1089/cbr.2011.0977. Epub 2011 Dec 7. Cancer Biother Radiopharm. 2012. PMID: 22149589 Free PMC article. - Targeting doxorubicin to epidermal growth factor receptors by site-specific conjugation of C225 to poly(L-glutamic acid) through a polyethylene glycol spacer.
Vega J, Ke S, Fan Z, Wallace S, Charsangavej C, Li C. Vega J, et al. Pharm Res. 2003 May;20(5):826-32. doi: 10.1023/a:1023454107190. Pharm Res. 2003. PMID: 12751641 - Cetuximab: preclinical evaluation of a monoclonal antibody targeting EGFR for radioimmunodiagnostic and radioimmunotherapeutic applications.
Milenic DE, Wong KJ, Baidoo KE, Ray GL, Garmestani K, Williams M, Brechbiel MW. Milenic DE, et al. Cancer Biother Radiopharm. 2008 Oct;23(5):619-31. doi: 10.1089/cbr.2008.0493. Cancer Biother Radiopharm. 2008. PMID: 18999934 Free PMC article. - Comparative analysis of metallic nanoparticles as exogenous soft tissue contrast for live in vivo micro-computed tomography imaging of avian embryonic morphogenesis.
Gregg CL, Butcher JT. Gregg CL, et al. Dev Dyn. 2016 Oct;245(10):1001-10. doi: 10.1002/dvdy.24433. Epub 2016 Aug 18. Dev Dyn. 2016. PMID: 27447729 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous